- Home
- LGVN vs BNGO Comparison
LGVN vs BNGO Comparison
Compare LGVN & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- BNGO
- Stock Information
- Founded
- LGVN 2014
- BNGO 2003
- Country
- LGVN United States
- BNGO United States
- Employees
- LGVN N/A
- BNGO N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- LGVN Health Care
- BNGO Industrials
- Exchange
- LGVN Nasdaq
- BNGO Nasdaq
- Market Cap
- LGVN 27.6M
- BNGO 24.3M
- IPO Year
- LGVN 2021
- BNGO 2018
- Fundamental
- Price
- LGVN $1.61
- BNGO $4.10
- Analyst Decision
- LGVN Strong Buy
- BNGO Buy
- Analyst Count
- LGVN 3
- BNGO 4
- Target Price
- LGVN $8.67
- BNGO $7.00
- AVG Volume (30 Days)
- LGVN 118.8K
- BNGO 215.9K
- Earning Date
- LGVN 05-13-2025
- BNGO 05-07-2025
- Dividend Yield
- LGVN N/A
- BNGO N/A
- EPS Growth
- LGVN N/A
- BNGO N/A
- EPS
- LGVN N/A
- BNGO N/A
- Revenue
- LGVN $2,392,000.00
- BNGO $30,776,000.00
- Revenue This Year
- LGVN $1.30
- BNGO $0.53
- Revenue Next Year
- LGVN $19.15
- BNGO $8.46
- P/E Ratio
- LGVN N/A
- BNGO N/A
- Revenue Growth
- LGVN 237.38
- BNGO N/A
- 52 Week Low
- LGVN $0.77
- BNGO $2.68
- 52 Week High
- LGVN $6.40
- BNGO $72.60
- Technical
- Relative Strength Index (RSI)
- LGVN 55.99
- BNGO 52.97
- Support Level
- LGVN $1.45
- BNGO $3.80
- Resistance Level
- LGVN $1.46
- BNGO $5.22
- Average True Range (ATR)
- LGVN 0.14
- BNGO 0.45
- MACD
- LGVN 0.02
- BNGO 0.12
- Stochastic Oscillator
- LGVN 100.00
- BNGO 55.91
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.